Sunday, December 27, 2015 11:12:38 AM
http://ih.advfn.com/p.php?pid=nmona&article=69614156
On December 4, 2015, Enzon Pharmaceuticals, Inc. (the “Company”) was advised by NASDAQ that an ex-dividend date of December 30, 2015 has been established for the $0.25 special cash dividend per share that was announced by the Company on December 3, 2015. As previously announced, the $0.25 special cash dividend per share is payable on December 29, 2015 to stockholders of record as of the close of business on December 14, 2015.
Recent ENZN News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
